North America Autotransfusion Devices Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Products and Accessories), Application (Cardiac Surgeries, Orthopedic Surgeries, Organ Transplantation, Trauma Procedures, and Others), and End User (Hospitals, Specialty Clinics, and Ambulatory Surgery Centers)
The autotransfusion devices market in North America is expected to grow from US$ 328.30 million in 2021 to US$ 448.50 million by 2028; it is estimated to grow at a CAGR of 4.6% from 2021 to 2028.
Organ transplantation is a surgical procedure performed in case of organ failure. Usually, organ transplantation is conducted for organs such as the heart, liver, and kidney; however, with rising cases of chronic diseases, transplantation is needed for other organs such as lungs, pancreas, cornea, and vascular tissues. These procedures generally take hours, and there is a lot of blood loss, and autotransfusion is one of the valuable methods to prevent blood loss. According to the United Network for Organ Sharing (UNOS), organ transplants conducted in the US have continuously increased, with over 41,000 transplants performed in 2021. Similarly, Canada has 22.2 donors per million population and is steadily improving, partially attributed to the figure of "Donation Physicians" - intensive care doctors who are responsible for organ donation. The public-private partnership in collaboration with transplant coordinators has made a significant contribution to the improvement of organ transplantation. Both developing and developed countries have seen an increase in organ transplant surgeries. Countries are progressing in terms of providing better and advanced medical treatments. Thus, the rising need for organ transplantation is among the key factors driving the demand for transplant diagnostics, such as autotransfusion devices.
North America Autotransfusion Devices Market Revenue and Forecast to 2028 (US$ Million)
Get more information on this report :
North America Autotransfusion Devices Market Segmentation
The North America autotransfusion devices market is segmented on the basis of type, application, end user, and country. The market, by type, is bifurcated into products and accessories. In 2021, the accessories segment held a larger market share. The market for the products segment is further segmented into intraoperative autotransfusion systems, postoperative autotransfusion systems, and dual-mode autotransfusion systems. In 2021, the intraoperative autotransfusion systems segment held the largest market share. The North America autotransfusion devices market, by application, is segmented into cardiac surgeries, orthopedic surgeries, organ transplantation, trauma procedures, and others. The cardiac surgeries segment held the largest market share in 2021. Based on end user, the market is segmented into hospitals, specialty clinics, and ambulatory surgical centers. The hospitals segment held the largest share of the market in 2021. Based on country, the market is segmented into the US, Canada, and Mexico. The US contributed a substantial share in 2021.
BD, Braile Biomedica, Fresenius SE & Co. KGaA, Haemonetics Corporation, LivaNova PLC, Medtronic, Redax S.p.A., SARSTEDT AG and Co. KG, Teleflex Incorporated, and Zimmer Biomet are among the leading companies in the North America autotransfusion devices market.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Autotransfusion Devices Market – By Type
1.3.2 North America Autotransfusion Devices Market – By Application
1.3.3 North America Autotransfusion Devices Market – By End User
1.3.4 North America Autotransfusion Devices Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Autotransfusion Devices Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.3 Experts Opinion
5. North America Autotransfusion Devices Market– Key Market Dynamics
5.1 Market Drivers
5.1.1 Rapid Increase in Chronic Diseases
5.1.2 Rise in Transplants
5.1.3 Difficulty in Obtaining Blood of Rare Groups
5.2 Market Restraints
5.2.1 Product Recalls
5.2.2 Risks Associated with Autotransfusion
5.3 Market Opportunities
5.3.1 Elevated Healthcare Expenditure in Emerging Economies
5.4 Future Trends
5.4.1 Technological Developments in Autotransfusion Devices
5.5 Impact Analysis
6. Autotransfusion Devices Market– North America Analysis
6.1 North America Autotransfusion Devices Market Revenue Forecast and Analysis
7. North America Autotransfusion Devices Market Analysis – By Type
7.1 Overview
7.2 North America Autotransfusion Devices Market Revenue Share, by Type (2021 and 2028)
7.3 Products
7.3.1 Overview
7.3.2 Products: North America Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Intraoperative Autotransfusion Systems
7.3.3.1 Overview
7.3.3.2 Intraoperative Autotransfusion Systems: North America Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Postoperative Autotransfusion Systems
7.3.4.1 Overview
7.3.4.2 Postoperative Autotransfusion Systems: North America Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)
7.3.5 Dual-Mode Autotransfusion Systems
7.3.5.1 Overview
7.3.5.2 Dual-Mode Autotransfusion Systems: North America Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Accessories
7.4.1 Overview
7.4.2 Accessories: North America Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)
8. North America Autotransfusion Devices Market Analysis – By Application
8.1 Overview
8.2 North America Autotransfusion Devices Market Revenue Share, by Application (2021 and 2028)
8.3 Cardiac Surgeries
8.3.1 Overview
8.3.2 Cardiac Surgeries: North America Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Orthopedic Surgeries
8.4.1 Overview
8.4.2 Orthopaedic Surgeries: North America Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Organ Transplantation
8.5.1 Overview
8.5.2 Organ Transplantation: North America Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Trauma Surgery Procedures
8.6.1 Overview
8.6.2 Trauma Surgery Procedures: North America Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: North America Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Autotransfusion Devices Market Analysis – By End User
9.1 Overview
9.2 Autotransfusion Devices Market Share, by End User (2021 and 2028)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: North America Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Specialty Clinics
9.4.1 Overview
9.4.2 Specialty Clinics: North America Autotransfusion Devices Market- Revenue and Forecast to 2028 (US$ Million)
9.5 Ambulatory Surgery Centers
9.5.1 Overview
9.5.2 Ambulatory Surgery Centers: North America Autotransfusion Devices Market- Revenue and Forecast to 2028 (US$ Million)
10. North America Autotransfusion Devices Market – Country Analysis
10.1 North America: Autotransfusion Devices Market
10.1.1 Overview
10.1.2 North America: Autotransfusion Devices Market, by Country, 2021 & 2028 (%)
10.1.2.1 US: Autotransfusion Devices Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.1 US: Autotransfusion Devices Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.2 US: Autotransfusion Devices Market, by Type, 2019–2028 (USD Million)
10.1.2.1.2.1 US: Autotransfusion Device Market, by Product, 2019–2028 (USD Million)
10.1.2.1.3 US: Autotransfusion Devices Market, by Application, 2019–2028 (USD Million)
10.1.2.1.4 US: Autotransfusion Devices Market, by End User, 2019–2028 (USD Million)
10.1.2.2 Canada: Autotransfusion Devices Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.1 Canada: Autotransfusion Devices Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2 Canada: Autotransfusion Devices Market, by Type, 2019–2028 (USD Million)
10.1.2.2.2.1 Canada: Autotransfusion Device Market, by Product, 2019–2028 (USD Million)
10.1.2.2.3 Canada: Autotransfusion Devices Market, by Application, 2019–2028 (USD Million)
10.1.2.2.4 Canada: Autotransfusion Devices Market, by End User, 2019–2028 (USD Million)
10.1.2.3 Mexico: Autotransfusion Devices Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.1 Mexico: Autotransfusion Devices Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2 Mexico: Autotransfusion Devices Market, by Type, 2019–2028 (USD Million)
10.1.2.3.2.1 Mexico: Autotransfusion Devices Market, by Product, 2019–2028 (USD Million)
10.1.2.3.3 Mexico: Autotransfusion Devices Market, by Application, 2019–2028 (USD Million)
10.1.2.3.4 Mexico: Autotransfusion Devices Market, by End User, 2019–2028 (USD Million)
11. North America Autotransfusion Devices Market–Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 Medtronic
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Fresenius SE & Co. KGaA
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Teleflex Incorporated
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 BD
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Zimmer Biomet
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Braile Biomedica
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Haemonetics Corporation
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 SARSTEDT AG and Co. KG
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 LivaNova PLC
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Redax S.p.A.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)
Table 2. US: Autotransfusion Devices Market, by Type, 2019–2028 (USD Million)
Table 3. US: Autotransfusion Device Market, by Product, 2019–2028 (USD Million)
Table 4. US: Autotransfusion Devices Market, by Application, 2019–2028 (USD Million)
Table 5. US: Autotransfusion Devices Market, by End User, 2019–2028 (USD Million)
Table 6. Canada: Autotransfusion Devices Market, by Type, 2019–2028 (USD Million)
Table 7. Canada: Autotransfusion Device Market, by Product, 2019–2028 (USD Million)
Table 8. Canada: Autotransfusion Devices Market, by Application, 2019–2028 (USD Million)
Table 9. Canada: Autotransfusion Devices Market, by End User, 2019–2028 (USD Million)
Table 10. Mexico: Autotransfusion Devices Market, by Type, 2019–2028 (USD Million)
Table 11. Mexico: Autotransfusion Devices Market, by Product, 2019–2028 (USD Million)
Table 12. Mexico: Autotransfusion Devices Market, by Application, 2019–2028 (USD Million)
Table 13. Mexico: Autotransfusion Devices Market, by End User, 2019–2028 (USD Million)
Table 14. Organic Developments in the North America Autotransfusion Devices Market
Table 15. Inorganic Developments in the North America Autotransfusion Devices Market
Table 16. Glossary of Terms, North America Autotransfusion Devices Market
LIST OF FIGURES
Figure 1. North America Autotransfusion Devices Market Segmentation
Figure 2. North America Autotransfusion Devices Market, By Country
Figure 3. North America Autotransfusion Devices Market Overview
Figure 4. Accessories Segment Held Largest Share of Product Segment in North America Autotransfusion Devices Market
Figure 5. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 7. North America: PEST Analysis
Figure 8. Experts Opinion
Figure 9. North America Autotransfusion Devices Market Impact Analysis of Driver and Restraints
Figure 10. North America Autotransfusion Devices Market– Revenue Forecast and Analysis – 2020- 2028
Figure 11. North America Autotransfusion Devices Market Revenue Share, by Type (2021 and 2028)
Figure 12. Products: North America Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Intraoperative Autotransfusion Systems: North America Autotransfusion Devices Market – Revenue and Forecast to 2028(US$ Million)
Figure 14. Postoperative Autotransfusion Systems: North America Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Dual-Mode Autotransfusion System: North America Autotransfusion Devices Market – Revenue and Forecast to 2028(US$ Million)
Figure 16. Accessories: North America Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. North America Autotransfusion Devices Market Revenue Share, by Application (2021 and 2028)
Figure 18. Cardiac Surgeries: North America Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Orthopaedic Surgeries: North America Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Organ Transplantation: North America Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Trauma Surgery Procedures: North America Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: North America Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Autotransfusion Devices Market Share, by End User (2021 and 2028 )
Figure 24. Hospitals: North America Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Specialty Clinics: North America Autotransfusion Devices Market- Revenue and Forecast to 2028 (US$ Million)
Figure 26. Ambulatory Surgery Centers: North America Autotransfusion Devices Market- Revenue and Forecast to 2028 (US$ Million)
Figure 27. North America: Autotransfusion Devices Market, by Key Country – Revenue (2021) (USD Million)
Figure 28. North America: Autotransfusion Devices Market, by Country, 2021 & 2028 (%)
Figure 29. US: Autotransfusion Devices Market – Revenue and Forecast to 2028 (USD Million)
Figure 30. Canada: Autotransfusion Devices Market – Revenue and Forecast to 2028 (USD Million)
Figure 31. Mexico: Autotransfusion Devices Market – Revenue and Forecast to 2028 (USD Million)
- BD
- Braile Biomedica
- Fresenius SE & Co. KGaA
- Haemonetics Corporation
- LivaNova PLC
- Medtronic
- Redax S.p.A.
- SARSTEDT AG and Co. KG
- Teleflex Incorporated
- Zimmer Biomet
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America Autotransfusion Devices Market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America Autotransfusion Devices Market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the Autotransfusion Devices Market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution